LPDX Stock News 3.16 05/13/2014 17:05:40 Liposcience Inc (LP

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Liposcience Inc (LPDX) 3.16 $LPDX

LipoScience Announces 2014 First Quarter Financial Results
GlobeNewswire - Mon May 12, 3:07PM CDT
LipoScience, Inc. (Nasdaq:LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced its financial results for the first quarter ended March 31, 2014.

LipoScience Announces Cash Management Actions
GlobeNewswire - Mon May 05, 5:30AM CDT
In a proactive effort to manage its cash, LipoScience, Inc. (Nasdaq:LPDX) today announced a reduction in workforce. This announcement represents the latest step in the Company's efforts to streamline its operations and further manage its operating costs. The action, taken in response to the Company's March 28, 2014 decision to terminate its contract with Health Diagnostic Laboratory, resulted in a reduction of approximately 22 positions across the Company.

Outcomes Study Supports Use of LDL Particle Number to Guide Statin Therapy in Patients at Elevated Cardiovascular Risk
PR Newswire - Fri May 02, 7:30AM CDT
LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data suggesting that the use of a target low-density lipoprotein particle (LDL-P) number to guide statin therapy in at-risk patients can reduce the risk of major adverse cardiovascular events (MACE) and death, compared to using standard LDL cholesterol (LDL-C) targets as a guide to therapy. Such benefits are particularly pronounced in patients in whom LDL-P and LDL-C numbers disagree, as is common in people with diabetes mellitus or coronary heart disease (CHD).

Omnicare Q1 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:30PM CDT
Omnicare Inc. (OCR) reported an earnings beat and in-line revenues for the first quarter of 2014, with both increasing on year-over-year bases.

LipoScience to Release First Quarter 2014 Financial Results
GlobeNewswire - Mon Apr 28, 3:17PM CDT
LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its first quarter 2014 financial results after the market close on Monday, May 12, 2014. An investor conference call will follow on the same day at 4:30 P.M. ET.

Patients Managed to Target LDL Particle Number Experience Fewer Cardiovascular Events Than Patients Managed to Target LDL Cholesterol, According to Study
PR Newswire - Mon Mar 31, 8:30AM CDT
LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data showing that patients managed to a target LDL particle (LDL-P) number, as measured by LipoScience's NMR LipoProfile test, achieved a 22 to 25 percent greater reduction in the risk of cardiovascular (CV) events over a three-year period compared to patients who attained LDL cholesterol (LDL-C) targets.

Nasdaq stocks posting largest volume increases
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Why LipoScience (LPDX) Stock Hit a One-Year Low Today
at The Street - Fri Mar 28, 1:03PM CDT
LipoScience (LPDX) fell to a one-year low on Friday after the diagnostics technology company decreased its first-quarter guidance to less than analysts' estimates after it ended its contract with Health Diagnostic Laboratory. The company reduced its...

LipoScience Announces Termination of Contract With Health Diagnostics Laboratory
GlobeNewswire - Fri Mar 28, 5:45AM CDT
LipoScience, Inc. (Nasdaq:LPDX) today announced the termination of its relationship with Health Diagnostics Laboratory, Inc. ("HDL Inc.", one of its laboratory customers. On March 17, 2014, HDL Inc. began offering its own non-FDA cleared test for the measurement of low density lipoprotein particles ("LDL-P". While the NMR LipoProfile(R) test may continue to be made available to HDL Inc. customers, LipoScience would like to ensure that physicians are able to differentiate with certainty which test result they are receiving. In order to ensure that patients and physicians are aware of and have unlimited access to the NMR LipoProfile(R) test, the only FDA-cleared and clinically validated test for measuring LDL-P and for managing patients with cardiovascular disease, LipoScience has terminated its contractual relationship with HDL Inc. The Company plans to mitigate the effects of loss of revenues from HDL Inc. by focusing on its relationships with other national, regional and local lab partners and by alerting physicians to use LipoScience lab partners that offer the NMR LipoProfile test.

LipoScience (LPDX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 8:33AM CDT
LipoScience (LPDX) Sees Hammer Chart Pattern: Time to Buy?

LipoScience Announces 2013 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Mon Mar 10, 3:05PM CDT
LipoScience, Inc. (Nasdaq:LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2013.

LipoScience to Present at Barclays Global Healthcare Conference
GlobeNewswire - Thu Feb 27, 6:45AM CST
LipoScience, Inc. (Nasdaq:LPDX) today announced that Howard Doran, President and Chief Executive Officer, and Lucy Martindale, Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference at 11:15 A.M. ET on Wednesday, March 12, 2014, in Miami, FL.

LipoScience to Release Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Feb 24, 3:05PM CST
LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its fourth quarter and fiscal year 2013 financial results after the market close on Monday, March 10, 2014. An investor conference call will follow on the same day at 4:30 P.M. ET.

LipoScience names Howard Doran as president & CEO
M2 - Thu Jan 23, 7:15AM CST
US-based diagnostics NMR company LipoScience Inc (NasdaqGM:LPDX) revealed on Wednesday the election of Howard Doran as its president, CEO and as a member of the board of directors, with effect from 3 February 2014.

LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
GlobeNewswire - Wed Jan 22, 7:00AM CST
LipoScience, Inc. (Nasdaq:LPDX) today announced the appointment of Howard Doran to the position of President and Chief Executive Officer and as a member of the LipoScience, Inc. Board of Directors, effective February 3, 2014.

LipoScience Inc to participate at 25th Annual Piper Jaffray Healthcare Conference in New York City
M2 - Thu Nov 28, 8:02AM CST
Diagnostic test company LipoScience Inc (NasdaqGM:LPDX) stated on Wednesday that it will take part at the 25th Annual Piper Jaffray Healthcare Conference in New York City.

LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Wed Nov 27, 5:30AM CST
LipoScience, Inc. (Nasdaq:LPDX) today announced that Bob Greczyn, Interim President and Chief Executive Officer, and Lucy Martindale, Executive Vice President and Chief Financial Officer, will present at the 25 Annual Piper Jaffray Healthcare Conference at 11:00 A.M. ET on Wednesday, December 4, 2013, in New York City.

LipoScience Announces Agreement With Scripps Health For First California Placement Of Vantera® Clinical Analyzer
PR Newswire - Mon Nov 25, 8:00AM CST
LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced an agreement to place the Vantera® Clinical Analyzer within Scripps Health facilities. The agreement, which marks the first placement of the Vantera Clinical Analyzer in the state of California, will make NMR lipoprotein testing on the analyzer accessible to customers of Scripps Health.

LipoScience to Discuss 2014 Guidance on Fourth Quarter 2013 Financial Results Conference Call
GlobeNewswire - Thu Nov 21, 3:05PM CST
LipoScience, Inc. (Nasdaq:LPDX) today announced that it will discuss revenue guidance for 2014 on the Company's Fourth Quarter 2013 conference call rather than on December 3, 2013 as previously announced. Management believes this timing will allow for greater visibility into factors that may influence 2014 revenue, including implementation of the Affordable Care Act (ACA) and publication of the latest laboratory fee schedule by the Centers of Medicare and Medicaid Services (CMS).

Real-World Data Presented At AHA Scientific Sessions Demonstrate Relationship Between Low-Density Lipoprotein Particle (LDL-P) Number And Future Risk Of Coronary Heart Disease
PR Newswire - Mon Nov 18, 9:30AM CST
LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced that low-density lipoprotein particle (LDL-P) number can predict cardiovascular events independently of LDL cholesterol (LDL-C) concentrations in a real-world environment, as presented in a poster session at the 2013 Scientific Sessions of the American Heart Association.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 180

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 104

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 111

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 133

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking the Future of Health with ELMCRx and ETS Partnership

Updated Category News Views 154

ELMCRx Solutions and ETS Partnership ELMCRx Solutions is forging new paths within the healthcare landscape through its strategic alliance with Emerging Therapy Solutions (ETS). This collaboration is tailored to address the innovative and costly challenges posed by cell and gene therapies (CGT). ELMCRx stands out as a pharmacy benefit manager (PBM) dedicated to providing...

Continue Reading
International Symposium on Microbes and Cancer Research

Updated Category News Views 203

International Symposium on Microbes and Cancer Research Set for March 2-3, the upcoming conference promises to bring together globally recognized experts from various fields related to cancer science. The event, hosted by Tampa General Hospital (TGH) Cancer Institute and the USF Health Morsani College of Medicine, will highlight critical intersections between microbes,...

Continue Reading
Freddie Mac Welcomes Matthew Abrusci as New General Counsel

Updated Category News Views 314

Freddie Mac Names Matthew Abrusci as General Counsel MCLEAN, Va. — Freddie Mac (OTCQB: FMCC) proudly announces the appointment of Matthew D. Abrusci as its new Executive Vice President, General Counsel, and Corporate Secretary. With his extensive experience in financial services, Abrusci is set to make significant contributions to the organization. Matthew Abrusci's...

Continue Reading
Energizer Holdings Declares Increased Dividend for Shareholders

Updated Category News Views 188

Energizer Holdings Announces Dividend for Shareholders Energizer Holdings, Inc. (NYSE: ENR) recently declared a quarterly dividend, highlighting the company’s ongoing dedication to its investors. The Board of Directors determined that each share of common stock will receive a dividend of $0.30, reflecting the organization's solid performance and commitment to returning...

Continue Reading
Tevogen Bio: Pioneering Cost-Effective Innovations in Biopharma

Updated Category News Views 199

Tevogen Bio's Innovative Approach to Healthcare As the biopharma sector navigates an increasingly competitive landscape, Tevogen Bio Holdings Inc. (NASDAQ: TVGN) stands out for its commitment to delivering groundbreaking medical solutions while maintaining affordability. This dedication is crucial as international competitors, particularly from China, develop drugs more...

Continue Reading